Inhaled Treprostinil in Pulmonary Hypertension

Embed Cite Participate Recommend

Aaron Waxman discusses research into patients with pulmonary hypertension due to interstitial lung disease and the effects of inhaled treprostinil.  Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.

Image courtesy of Aaron Waxman

Image courtesy of interviewee

Log-in or Sign-up to Faculti
Currently viewing as guest. You have insight(s) remaining for this month.

Leave a Reply

Your email address will not be published.

Copyright © Faculti Media Limited 2023. All rights reserved.
Recommend Faculti to your librarian

Thousands of engaging insights, delivered at the world's leading institutions. 
Librarians welcome and value students, faculty and staff recommendations, and we aim to facilitate these suggestions in an impactful way.

error:
Chromecast or Airplay insights to your smart tv via our new video player
This is default text for notification bar